Drayton currently serves as the CFO of Quantum-Si, a life sciences company focused on technology related to protein sequencing and genomics for the healthcare industry.
“We are delighted to welcome Claudia to our board of directors,” said Chip McClure, chairman. “Her outstanding career as a finance leader, in roles ranging from public accounting to sophisticated medical devices and, in recent years, biotech companies, will prove invaluable to both our Audit Committee and our Board in general.”
“The potential for 3D printing in medical device applications, as well as a tremendous range of biological applications within the human body, offer outstanding opportunities for growth and value creation as new solutions are brought to patients in need around the world,” added Drayton.